samedan logo
 
 
spacer
home > pmps > winter 2017 > thinking human
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Thinking Human

Two main challenges with human factors (HF) stand out at the moment: one is that it has become a ‘hot topic’ that people do not want to hear about anymore; the other is that it is perhaps not clear what the lasting and valuable contribution of it will be. However, it can have real benefits in the development of inhalers. It is important to look at the HF perspective and how it might contribute to future advancements in both medical devices and technology.

Innovative Inhalers


It is not helpful for HF to be possessive, or seek to claim ownership of any particular aspect of the development of inhalers or their life in the world. This perspective is just one voice among many, and countless progressions in inhalers occurred before HF were identified as an integral part of the design process. There are three aspects of the inhaler-user relationship where the industry looks to improve.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Julian Dixon is Director of HF at Team Consulting, the leading medical device development consultancy based in Cambridge, UK. He takes an active role in understanding emerging FDA expectations and practices with regard to HF, particularly as they apply to combination products. Predominantly in the respiratory and parenteral sectors, Julian has worked on a large number of drug delivery device development projects and has fulfilled a range of consultancy roles for clients including HF, facilitation, decision support and technical problem solving.
spacer
Julian Dixon
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ACRO Releases Diversity and Inclusion Principles Statement in Support of More Diverse Clinical Trials


More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement